Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
- Om Prakash Choudhary(corresponding author),
- Priyanka,
- Jivan Q. Ahmed,
- Teroj A. Mohammed,
- Indraj Singh,
- Central Agricultural University (I),
- University of Duhok,
- Community Health Centre,
- ,
- Fundacion Universitaria Autonoma de las Américas
Research Output:
Contribution to journal
Comment/debate
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Comment/debate
Original language
EnglishPages from-to (Number of pages)
Pages 5135-5138 (4 pages)Journal (Volume, Issue Number)
Human Vaccines and Immunotherapeutics (Volume 17, Issue 12)Publication milestones
- Published - 2021
Publication status
Published - 2021
ISSN
2164-5515Publication IDs
- Scopus: 85121442707
- PubMed: 34898381
Abstract
Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19.
Publication metrics
Metrics
Sustainable Development Goals
SDG 3 Good Health and Well